3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
23
Lymphoma, Non-Hodgkin
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Lymphoma, Mantle-Cell
12
Lymphoma
12
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
8
Burkitt Lymphoma
8
Lymphoma, B-Cell
6
Recurrence
5
Neoplasms
4
Leukemia, Hairy Cell
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoproliferative Disorders
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Infections
2
Epstein-Barr Virus Infections
2
beta-Thalassemia
1
Thalassemia
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphatic Diseases
1
Interventions
Biopsy
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Carboplatin
3
larotrectinib
2
erdafitinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Etoposide
2
Cyclophosphamide
2
Cisplatin
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
ivosidenib
1
irinotecan sucrosofate
1
entrectinib
1
elacestrant
1
budigalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Rituximab
×
30 days
×
Clear all
No trials found.